IL2 and COVID-19: In patients admitted to medical emergencies with a confirmed diagnosis of COVID-19, it is important to perform a joint evaluation of demographic characteristics, clinical parameters, interleukins (IL-2, IL-6, IL-7, IL-10, IL-17) and sP-selectin.